TNFSF10 and neoplasm: In this regard, ACDCRGDCFC a targeting peptide to human αVβ3 and αVβ5 on tumour blood vessels was fused to TRAIL forming what is called RGD-L-TRAIL and improved the therapeutic index of TRAIL in vitro and in vivo [82].